1. Home
  2. LXRX vs AOUT Comparison

LXRX vs AOUT Comparison

Compare LXRX & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • AOUT
  • Stock Information
  • Founded
  • LXRX 1995
  • AOUT 2020
  • Country
  • LXRX United States
  • AOUT United States
  • Employees
  • LXRX N/A
  • AOUT N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • AOUT Ordnance And Accessories
  • Sector
  • LXRX Health Care
  • AOUT Industrials
  • Exchange
  • LXRX Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • LXRX 124.4M
  • AOUT 130.2M
  • IPO Year
  • LXRX 2000
  • AOUT N/A
  • Fundamental
  • Price
  • LXRX $0.51
  • AOUT $10.41
  • Analyst Decision
  • LXRX Buy
  • AOUT Strong Buy
  • Analyst Count
  • LXRX 4
  • AOUT 2
  • Target Price
  • LXRX $3.67
  • AOUT $15.50
  • AVG Volume (30 Days)
  • LXRX 32.2M
  • AOUT 58.3K
  • Earning Date
  • LXRX 05-01-2025
  • AOUT 03-06-2025
  • Dividend Yield
  • LXRX N/A
  • AOUT N/A
  • EPS Growth
  • LXRX N/A
  • AOUT N/A
  • EPS
  • LXRX N/A
  • AOUT N/A
  • Revenue
  • LXRX $31,081,000.00
  • AOUT $206,678,000.00
  • Revenue This Year
  • LXRX N/A
  • AOUT $5.93
  • Revenue Next Year
  • LXRX $63.36
  • AOUT $6.60
  • P/E Ratio
  • LXRX N/A
  • AOUT N/A
  • Revenue Growth
  • LXRX 2481.48
  • AOUT 4.91
  • 52 Week Low
  • LXRX $0.28
  • AOUT $7.45
  • 52 Week High
  • LXRX $2.45
  • AOUT $17.91
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 53.30
  • AOUT 36.73
  • Support Level
  • LXRX $0.48
  • AOUT $10.16
  • Resistance Level
  • LXRX $0.60
  • AOUT $11.18
  • Average True Range (ATR)
  • LXRX 0.09
  • AOUT 0.79
  • MACD
  • LXRX 0.01
  • AOUT 0.01
  • Stochastic Oscillator
  • LXRX 42.86
  • AOUT 14.17

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: